{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T10:48:01Z","timestamp":1758192481547,"version":"3.44.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,17]]},"DOI":"10.7759\/cureus.92560","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T19:34:47Z","timestamp":1758137687000},"source":"Crossref","is-referenced-by-count":0,"title":["Treatment of a Pediatric Arterial Ischemic Stroke With Tenecteplase"],"prefix":"10.7759","author":[{"given":"Mostafa","family":"Alsabbagh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maham","family":"Alvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aryaan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Venizelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073818767039","article-title":"Pediatric stroke rates over 17 years: report from a population-based study","volume":"33","author":"Lehman LL","year":"2018","unstructured":"Lehman LL, Khoury JC, Taylor JM, et al.. Pediatric stroke rates over 17 years: report from a population-based study. J Child Neurol. 2018, 33:463-7. 10.1177\/0883073818767039","journal-title":"J Child Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e31124","article-title":"Risk factors for pediatric ischemic stroke and intracranial hemorrhage: a national electronic health record based study","volume":"10","author":"Fraser S","year":"2024","unstructured":"Fraser S, Levy SM, Moreno A, Zhu G, Savitz S, Zha A, Wu H. Risk factors for pediatric ischemic stroke and intracranial hemorrhage: a national electronic health record based study. Heliyon. 2024, 10:e31124. 10.1016\/j.heliyon.2024.e31124","journal-title":"Heliyon"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: a report from the American Heart Association","volume":"147","author":"Tsao CW","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, et al.. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation. 2023, 147:e93-621. 10.1161\/CIR.0000000000001123","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.008210","article-title":"Thrombolysis in pediatric stroke study","volume":"46","author":"Rivkin MJ","year":"2015","unstructured":"Rivkin MJ, deVeber G, Ichord RN, et al.. Thrombolysis in pediatric stroke study. Stroke. 2015, 46:880-5. 10.1161\/STROKEAHA.114.008210","journal-title":"Stroke"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.027225","article-title":"Risk of intracranial hemorrhage following intravenous tPA (tissue-type plasminogen activator) for acute stroke is low in children","volume":"51","author":"Amlie-Lefond C","year":"2020","unstructured":"Amlie-Lefond C, Shaw DW, Cooper A, et al.. Risk of intracranial hemorrhage following intravenous tPA (tissue-type plasminogen activator) for acute stroke is low in children. Stroke. 2020, 51:542-8. 10.1161\/STROKEAHA.119.027225","journal-title":"Stroke"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/00912700022009125","article-title":"Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarction","volume":"40","author":"Modi NB","year":"2000","unstructured":"Modi NB, Fox NL, Clow FW, Tanswell P, Cannon CP, Van de Werf F, Braunwald E. Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarction. J Clin Pharmacol. 2000, 40:508-15. 10.1177\/00912700022009125","journal-title":"J Clin Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.123.042951","article-title":"Tenecteplase in acute stroke: what about the children?","volume":"54","author":"Sun LR","year":"2023","unstructured":"Sun LR, Wilson JL, Waak M, Kiskaddon A, Goldenberg NA, Jordan LC, Barry M. Tenecteplase in acute stroke: what about the children?. Stroke. 2023, 54:1950-3. 10.1161\/STROKEAHA.123.042951","journal-title":"Stroke"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.029749","article-title":"Tenecteplase thrombolysis for acute ischemic stroke","volume":"51","author":"Warach SJ","year":"2020","unstructured":"Warach SJ, Dula AN, Milling TJ Jr. Tenecteplase thrombolysis for acute ischemic stroke. Stroke. 2020, 51:3440-51. 10.1161\/STROKEAHA.120.029749","journal-title":"Stroke"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)70017-7","article-title":"Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study","volume":"14","author":"Huang X","year":"2015","unstructured":"Huang X, Cheripelli BK, Lloyd SM, et al.. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study. Lancet Neurol. 2015, 14:368-76. 10.1016\/S1474-4422(15)70017-7","journal-title":"Lancet Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716405","article-title":"Tenecteplase versus alteplase before thrombectomy for ischemic stroke","volume":"378","author":"Campbell BC","year":"2018","unstructured":"Campbell BC, Mitchell PJ, Churilov L, et al.. Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med. 2018, 378:1573-82. 10.1056\/NEJMoa1716405","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2023.11.003","article-title":"Tenecteplase in pediatric stroke: ready or not","volume":"151","author":"Wilson JL","year":"2024","unstructured":"Wilson JL, Waak M, Barry M, Jordan LC, Sun LR. Tenecteplase in pediatric stroke: ready or not. Pediatr Neurol. 2024, 151:17-20. 10.1016\/j.pediatrneurol.2023.11.003","journal-title":"Pediatr Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181cbcd48","article-title":"The 5-year direct medical cost of neonatal and childhood stroke in a population-based cohort","volume":"74","author":"Gardner MA","year":"2010","unstructured":"Gardner MA, Hills NK, Sidney S, Johnston SC, Fullerton HJ. The 5-year direct medical cost of neonatal and childhood stroke in a population-based cohort. Neurology. 2010, 74:372-8. 10.1212\/WNL.0b013e3181cbcd48","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/1076029620929092","article-title":"The developing balance of thrombosis and hemorrhage in pediatric surgery: clinical implications of age-related changes in hemostasis","volume":"26","author":"Achey MA","year":"2020","unstructured":"Achey MA, Nag UP, Robinson VL, Reed CR, Arepally GM, Levy JH, Tracy ET. The developing balance of thrombosis and hemorrhage in pediatric surgery: clinical implications of age-related changes in hemostasis. Clin Appl Thromb Hemost. 2020, 26:10.1177\/1076029620929092","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.109.192362","article-title":"Comprehensive overview of nursing and interdisciplinary care of the acute ischemic stroke patient: a scientific statement from the American Heart Association","volume":"40","author":"Summers D","year":"2009","unstructured":"Summers D, Leonard A, Wentworth D, et al.. Comprehensive overview of nursing and interdisciplinary care of the acute ischemic stroke patient: a scientific statement from the American Heart Association. Stroke. 2009, 40:2911-44. 10.1161\/STROKEAHA.109.192362","journal-title":"Stroke"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-015-0222-x","article-title":"Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine","volume":"24","author":"Frontera JA","year":"2016","unstructured":"Frontera JA, Lewin JJ 3rd, Rabinstein AA, et al.. Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine. Neurocrit Care. 2016, 24:6-46. 10.1007\/s12028-015-0222-x","journal-title":"Neurocrit Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/391753-treatment-of-a-pediatric-arterial-ischemic-stroke-with-tenecteplase","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T19:34:48Z","timestamp":1758137688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/391753-treatment-of-a-pediatric-arterial-ischemic-stroke-with-tenecteplase"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.92560","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,17]]}}}